Litcius/Paper detail

Aptamer-protamine-siRNA nanoparticles in targeted therapy of ErbB3 positive breast cancer cells

Xiang Xu, Li Li, Xiaolan Li, Deding Tao, Peng Zhang, Jianping Gong

2020International Journal of Pharmaceutics42 citationsDOI

Topics & Concepts

SurvivinSmall interfering RNAIn vivoCancer researchOncogeneCancerIn vitroRNA interferenceCell cycleAptamerChemistryMedicineMolecular biologyBiologyCell cultureTransfectionRNAInternal medicineBiochemistryBiotechnologyGeneGeneticsRNA Interference and Gene DeliveryMicroRNA in disease regulationAdvanced biosensing and bioanalysis techniques
Aptamer-protamine-siRNA nanoparticles in targeted therapy of ErbB3 positive breast cancer cells | Litcius